Neurocrine Biosciences reported $47.3M in EBITDA for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -14.32M 28.46M
Adamas Pharmaceuticals ADMS:US -5502000 3.51M
Agios Pharmaceuticals AGIO:US $ -88.94M 0.07M
Alexion Pharmaceuticals ALXN:US $ 892.3M 186.4M
ALKERMES ALKS:US $ -0.27M 23.16M
Alnylam Pharmaceuticals ALNY:US $ -169.89M 35.54M
Amgen AMGN:US $ 3228M 40M
Aptinyx Inc APTX:US $ -21106000 1.34M
Biogen BIIB:US $ 991.8M 155.8M
Biomarin Pharmaceutical BMRN:US $ -9.16M 48.05M
Exelixis EXEL:US $ 56.42M 70.25M
Gilead Sciences GILD:US $ 4370M 1605M
Gw Pharmaceuticals GWPH:US $ -17.18M 2.02M
Halozyme Therapeutics HALO:US $ 76.34M 17.51M
Intercept Pharmaceuticals ICPT:US $ -5.41M 6.8M
Intra Cellular Therapies ITCI:US $ -77.19M 8.17M
Nektar Therapeutics NKTR:US $ -109.98M 3.32M
Neurocrine Biosciences NBIX:US $ 47.3M 23.1M
Pfizer PFE:US $ 10235M 2245M
Prothena PRTA:US 109.53M 81.29M
Regeneron Pharmaceuticals REGN:US $ 1920.4M 1497.9M
Repligen RGEN:US $ 59.7M 2.24M
Rigel Pharmaceuticals RIGL:US $ -19.52M 6.73M
Sarepta Therapeutics SRPT:US $ -23.96M 135.16M
Teva Pharmaceutical TEVA:IT 1.14B 1000K
Ultragenyx Pharmaceutical RARE:US $ -86.61M 6.96M
Vertex Pharmaceuticals VRTX:US $ 1087.41M 1092.53M
Xoma XOMA:US $ -3343000 281K
YTE INCY:US $ 262.16M 92.39M
Zogenix ZGNX:US $ -51.9M 1.17M